Frequency Therapeutics Stock Book Value Per Share
| FREQDelisted Stock | USD 0.52 0.03 5.45% |
Frequency Therapeutics fundamentals help investors to digest information that contributes to Frequency Therapeutics' financial success or failures. It also enables traders to predict the movement of Frequency Stock. The fundamental analysis module provides a way to measure Frequency Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Frequency Therapeutics stock.
Frequency |
Frequency Therapeutics Company Book Value Per Share Analysis
Frequency Therapeutics' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Frequency Therapeutics Book Value Per Share | 0.99 X |
Most of Frequency Therapeutics' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Frequency Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Frequency Therapeutics is about 0.995 times. This is 158.53% lower than that of the Biotechnology sector and 100.4% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.95% higher than that of the company.
Frequency Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Frequency Therapeutics' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Frequency Therapeutics could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics of similar companies.Frequency Therapeutics is currently under evaluation in book value per share category among its peers.
Frequency Fundamentals
| Return On Equity | -1.0 | |||
| Return On Asset | -0.42 | |||
| Current Valuation | 512.86 M | |||
| Shares Outstanding | 36.52 M | |||
| Shares Owned By Insiders | 7.26 % | |||
| Shares Owned By Institutions | 14.12 % | |||
| Number Of Shares Shorted | 365.89 K | |||
| Price To Earning | (7.43) X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 7.50 X | |||
| Gross Profit | (42.02 M) | |||
| EBITDA | (80.62 M) | |||
| Net Income | (81.58 M) | |||
| Cash And Equivalents | 111.02 M | |||
| Cash Per Share | 3.15 X | |||
| Total Debt | 42.95 M | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 6.77 X | |||
| Book Value Per Share | 0.99 X | |||
| Cash Flow From Operations | (58.24 M) | |||
| Short Ratio | 3.51 X | |||
| Earnings Per Share | (1.90) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 46 | |||
| Beta | 0.77 | |||
| Market Capitalization | 10.94 M | |||
| Total Asset | 121.24 M | |||
| Retained Earnings | (261.67 M) | |||
| Working Capital | 66.47 M | |||
| Current Asset | 238.83 M | |||
| Current Liabilities | 56.95 M | |||
| Z Score | -4.41 | |||
| Net Asset | 121.24 M |
About Frequency Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Frequency Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Frequency Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Frequency Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.66 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.61 | PBCRY | Bank Central Asia | PairCorr |
| 0.58 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.54 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.51 | PTAIY | Astra International Tbk | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |